h-NTPDase-IN-1

h-NTPDase-IN-1

• UNSPSC Description: h-NTPDase-IN-1 (Compound 3i) is a h-NTPDase inhibitor (IC50: 2.88 μM and 0.72 μM for h-NTPDase1 and h-NTPDase3 respectively). h-NTPDase-IN-1 can be used for research of thrombosis, inflammation, diabetes, and cancer[1].
• Target Antigen: NTPDase
• Type: Reference compound
• Related Pathways: Immunology/Inflammation
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/h-ntpdase-in-1.html
• Solubility: 10 mM in DMSO
• Smiles: O=S(C1=CC=C(Cl)C(C(N2CCOCC2)=O)=C1)(NC3=CC=C(Br)C=C3)=O
• Molecular Weight: 459.74
• References & Citations: [1]Zaigham ZH,et al. Synthesis and biological evaluation of sulfamoyl benzamide derivatives as selective inhibitors for h-NTPDases. RSC Adv. 2023 Jul 11;13(30):20909-20915.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported